Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3154)
All Articles published online
|
Mar 7, 2005 (publication date) through Nov 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Zhu BD, Yuan SJ, Zhao QC, Li X, Li Y, Lu QY. Antitumor effect of Gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor, combined with cytotoxic agent on murine hepatocellular carcinoma. World J Gastroenterol 2005; 11(9): 1382-1386 [PMID: 15761981 DOI: 10.3748/wjg.v11.i9.1382] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v11/i9/1382.htm |
| Number | Citing Articles |
| 1 |
Jianhua Zhou, Wei Zheng, Longhui Cao, Min Liu, Feng Han, Anhua Li. Antiangiogenic Tumor Treatment. Academic Radiology 2010; 17(5): 646 doi: 10.1016/j.acra.2010.01.008
|
| 2 |
Zhengyu Wei, Cataldo Doria, Yuan Liu. Targeted Therapies in the Treatment of Advanced Hepatocellular Carcinoma. Clinical Medicine Insights: Oncology 2013; 7 doi: 10.4137/CMO.S7633
|
| 3 |
Jian-hua Zhou, Long-hui Cao, Ji-bin Liu, Wei Zheng, Min Liu, Rong-zhen Luo, Feng Han, An-hua Li. Quantitative Assessment of Tumor Blood Flow in Mice after Treatment with Different Doses of an Antiangiogenic Agent with Contrast-enhanced Destruction-Replenishment US. Radiology 2011; 259(2): 406 doi: 10.1148/radiol.10101339
|
| 4 |
Karin Komposch, Maria Sibilia. EGFR Signaling in Liver Diseases. International Journal of Molecular Sciences 2015; 17(1): 30 doi: 10.3390/ijms17010030
|
| 5 |
G Milano, J-P Spano, B Leyland-Jones. EGFR-targeting drugs in combination with cytotoxic agents: from bench to bedside, a contrasted reality. British Journal of Cancer 2008; 99(1): 1 doi: 10.1038/sj.bjc.6604373
|
| 6 |
Caecilia HC Sukowati, Natalia Rosso, Lory S Crocè, Claudio Tiribelli. Hepatic cancer stem cells and drug resistance: Relevance in targeted therapies for hepatocellular carcinoma. World Journal of Hepatology 2010; 2(3): 114-126 doi: 10.4254/wjh.v2.i3.114
|
| 7 |
Shan-Zhou Huang, Meng-Ning Wei, Jia-Rong Huang, Zi-Jian Zhang, Wen-Ji Zhang, Qi-Wei Jiang, Yang Yang, Huan-Yu Wang, Hui-Lin Jin, Kun Wang, Zi-Hao Xing, Meng-Ling Yuan, Yao Li, Xiao-Shun He, Zhi Shi, Qi Zhou. Targeting TF-AKT/ERK-EGFR Pathway Suppresses the Growth of Hepatocellular Carcinoma. Frontiers in Oncology 2019; 9 doi: 10.3389/fonc.2019.00150
|
| 8 |
Ariel Ka-Man Chow, Simon Wing-Lung Yau, Lui Ng. Novel molecular targets in hepatocellular carcinoma. World Journal of Clinical Oncology 2020; 11(8): 589-605 doi: 10.5306/wjco.v11.i8.589
|
| 9 |
Jian-Hua Zhou, Wei Zheng, Long-Hui Cao, Min Liu, Rong-Zhen Luo, Feng Han, Pei-Hong Wu, An-Hua Li. Contrast-enhanced ultrasonic parametric perfusion imaging in the evaluation of antiangiogenic tumor treatment. European Journal of Radiology 2012; 81(6): 1360 doi: 10.1016/j.ejrad.2011.01.099
|
| 10 |
Nouf Juaid, Amr Amin, Ali Abdalla, Kevin Reese, Zaenah Alamri, Mohamed Moulay, Suzan Abdu, Nabil Miled. Anti-Hepatocellular Carcinoma Biomolecules: Molecular Targets Insights. International Journal of Molecular Sciences 2021; 22(19): 10774 doi: 10.3390/ijms221910774
|
| 11 |
Wen-Hua Zhang, Ming-Hua Lv, Jun Hai, Qin-Pu Wang, Qin Wang. Dicranostigma leptopodum (maxim) fedde induced apoptosis in SMMC-7721 human hepatoma cells and inhibited tumor growth in mice. Natural Science 2010; 2(05): 457 doi: 10.4236/ns.2010.25056
|
| 12 |
Ruixia Zhang, Ruizhou Wang, Shipeng Zhao, Dan Chen, Fusheng Hao, Bo Wang, Jin Zhang, Yingying Ma, Xingyi Chen, Xiaojuan Gao, Lu Han, Changcai Bai. Extraction, Separation, Antitumor Effect, and Mechanism of Alkaloids in Sophora alopecuroides: A Review. Separations 2022; 9(11): 380 doi: 10.3390/separations9110380
|
| 13 |
Anne F. Buckley, Lawrence J. Burgart, Vaibhav Sahai, Sanjay Kakar. Epidermal Growth Factor Receptor Expression and Gene Copy Number in Conventional Hepatocellular Carcinoma. American Journal of Clinical Pathology 2008; 129(2): 245 doi: 10.1309/WF10QAAED3PP93BH
|
| 14 |
Chiung‐Ing Wong, Hui‐Ling Yap, Seng‐Gee Lim, Jia‐Yi Guo, Boon‐Cher Goh, Soo‐Chin Lee. Lack of somatic ErbB2 tyrosine kinase domain mutations in hepatocellular carcinoma. Hepatology Research 2008; 38(8): 838 doi: 10.1111/j.1872-034X.2008.00365.x
|
| 15 |
Cong Li, Xia Wu, Honghai Zhang, Gengxia Yang, Meijun Hao, Shoupeng Sheng, Yu Sun, Jiang Long, Caixia Hu, Xicai Sun, Li Li, Jiasheng Zheng. A Huaier polysaccharide inhibits hepatocellular carcinoma growth and metastasis. Tumor Biology 2015; 36(3): 1739 doi: 10.1007/s13277-014-2775-2
|
| 16 |
Burgess B. Freeman, Najat C. Daw, J. Russell Geyer, Wayne L. Furman, Clinton F. Stewart. Evaluation of Gefitinib for Treatment of Refractory Solid Tumors and Central Nervous System Malignancies in Pediatric Patients. Cancer Investigation 2006; 24(3): 310 doi: 10.1080/07357900600632058
|
| 17 |
Christèle Desbois‐Mouthon, Wulfran Cacheux, Marie‐José Blivet‐Van Eggelpoël, Véronique Barbu, Laetitia Fartoux, Raoul Poupon, Chantal Housset, Olivier Rosmorduc. Impact of IGF‐1R/EGFR cross‐talks on hepatoma cell sensitivity to gefitinib. International Journal of Cancer 2006; 119(11): 2557 doi: 10.1002/ijc.22221
|
| 18 |
Michael Höpfner, Alexander Huether, Andreas P. Sutter, Viola Baradari, Detlef Schuppan, Hans Scherübl. Blockade of IGF-1 receptor tyrosine kinase has antineoplastic effects in hepatocellular carcinoma cells. Biochemical Pharmacology 2006; 71(10): 1435 doi: 10.1016/j.bcp.2006.02.006
|
| 19 |
Jonathan D. Schwartz, Josep M. Llovet. Molecular Targeting in Oncology. Cancer Drug Discovery and Development 2008; : 165 doi: 10.1007/978-1-59745-337-0_8
|
| 20 |
Dianguo Dong, Xiuqi Song, Weishan Xue, Yanluo Wei. The effect of Tagalsin on mice with transplanted H22 Hepatocarcinoma. The Chinese-German Journal of Clinical Oncology 2011; 10(3): 153 doi: 10.1007/s10330-011-0754-2
|
| 21 |
Tarun Sahu, Arundhati Mehta, Henu Kumar Verma, L.V.K.S. Bhaskar. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 2. 2022; : 227 doi: 10.1016/B978-0-323-98807-0.00020-X
|
| 22 |
Chentao Lin, Wei Wei, Jinchun Zhang, Shilian Liu, Yanxin Liu, Dexian Zheng. Formyl peptide receptor-like 1–mediated endogenousTRAILgene expression with tumoricidal activity. Molecular Cancer Therapeutics 2007; 6(10): 2618 doi: 10.1158/1535-7163.MCT-07-0286
|